PMID- 21906245
OWN - NLM
STAT- MEDLINE
DCOM- 20120221
LR  - 20110912
IS  - 1751-7133 (Electronic)
IS  - 1527-5299 (Linking)
VI  - 17
IP  - 5
DP  - 2011 Sep-Oct
TI  - Pharmacologic therapy for New York Heart Association class IV heart failure.
PG  - 213-9
LID - 10.1111/j.1751-7133.2011.00235.x [doi]
AB  - As the incidence of heart failure increases, the number of patients with advanced 
      heart failure is anticipated to grow. Substantial progress in the treatment of 
      heart failure has been achieved over the past few decades. Several classes of 
      medications have been studied and found effective, including beta-blockers, 
      angiotensin converting enzyme inhibitors or angiotensin receptor blockers, 
      aldosterone antagonists, vasodilators, digoxin, and inotropes. The evidence base 
      for the use of these medications in the treatment of patients with New York Heart 
      Association (NYHA) class IV heart failure is reviewed.
CI  - (c) 2011 Wiley Periodicals, Inc.
FAU - Caccamo, Marco A
AU  - Caccamo MA
AD  - Division of Cardiovascular Disease, Department of Cardiology, University of 
      Minnesota Medical Center, Minneapolis, MN 55455, USA.
FAU - Eckman, Peter M
AU  - Eckman PM
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20110721
PL  - United States
TA  - Congest Heart Fail
JT  - Congestive heart failure (Greenwich, Conn.)
JID - 9714174
SB  - IM
MH  - Heart Failure/classification/*drug therapy
MH  - Humans
MH  - New York
MH  - Severity of Illness Index
MH  - Societies, Medical
EDAT- 2011/09/13 06:00
MHDA- 2012/02/22 06:00
CRDT- 2011/09/13 06:00
PHST- 2011/09/13 06:00 [entrez]
PHST- 2011/09/13 06:00 [pubmed]
PHST- 2012/02/22 06:00 [medline]
AID - 10.1111/j.1751-7133.2011.00235.x [doi]
PST - ppublish
SO  - Congest Heart Fail. 2011 Sep-Oct;17(5):213-9. doi: 
      10.1111/j.1751-7133.2011.00235.x. Epub 2011 Jul 21.